EDIT Competitors & Alternatives
Compare Editas Medicine, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
EDIT
Main Stock$2.47
Tradestie Score
51
Market Cap
$319.22M
Revenue Growth
-0.2%
Analyst Upside
+122.7%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$351.85
|
$160.70B | 24.5 | 58 | Compare |
|
GILD
Gilead Sciences Inc
|
$139.37
|
$137.92B | 20.1 | 54 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$730.25
|
$46.96B | 36.0 | 61 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$88.88
|
$24.57B | - | 54 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$183.33
|
$22.61B | 21.3 | 56 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$131.74
|
$13.59B | 27.6 | 64 | Compare |
|
EXEL
Exelixis Inc
|
$42.89
|
$11.09B | 14.9 | 63 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$50.80
|
$10.74B | - | 57 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.04
|
$10.04B | 19.3 | 61 | Compare |
|
TECH
Bio-Techne Corp.
|
$52.26
|
$9.33B | 98.2 | 59 | Compare |
More EDIT Analysis
Data updated: Apr 01, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry